Among previously not reported associations with overall survival were mutations in GATA3 and FANCE genes in colorectal cancer, mutations in gene PTPN11 in glioma, and mutations in RNF43, MSH6 and FBXW7 genes in endometrial cancer. This evidence concerns the gene GATA3 and central nervous system cancer.